NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/23/2026
Back to search
Official data from USPTO
MISSION: GENOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MISSION: GENOME
ST13
US500000098870919Class
35, 41, 44
Filing
98870919
Registration
8309920
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/23/2026
Trademark type
Word
Nice classes
35, 41, 44
Filing date
11/25/2024
Registration date
06/23/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2026
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/16/2024
First use in commerce
11/16/2024
Drawing code
4
Owner type
99
Owner location
Zug, CH
Examiner
YAO, GRETTA
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Rocket Pharmaceuticals GmbH
Representatives
DANNY AWDEH
Technical classification
Nice Classes
Class 35Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting physician awareness of rare genetic diseases; compilation of patient genetic demographic and testing datahealth-related information associated with rare diseases into a computer database
Class 41
Providing education servicesonline and in-person classesseminarsworkshops in the field of genetic testingscreening; Providing education servicesonline and in-person classesseminarsworkshops in the field of rare genetic diseases; Providing education servicesonline and in-person classesseminarsworkshops in the field of benefits of early genetic testing and screening for the detection of rare genetic diseases
Class 44
Providing genetic testing and counseling assistance for medicaldiagnostic or treatment purposes relating to rare genetic diseases; Health counseling relating to rare genetic diseases; Providing websites featuring educational information in the field of genetic testing for medical purposesscreening for medical purposeshealth counseling relating to rare genetic diseases
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2026
PUBO
PUBLISHED FOR OPPOSITION
05/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2026
EXPT
EXPARTE APPEAL TERMINATED
04/06/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2026
EXPI
EX PARTE APPEAL-INSTITUTED
03/16/2026
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/16/2026
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
03/16/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/13/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/11/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/11/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/13/2025
GNFR
FINAL REFUSAL E-MAILED
09/13/2025
CNFR
FINAL REFUSAL WRITTEN
09/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/20/2025
GNRT
NON-FINAL ACTION E-MAILED
05/20/2025
CNRT
NON-FINAL ACTION WRITTEN
05/20/2025
DOCK
ASSIGNED TO EXAMINER
05/16/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/13/2025
NWAP
NEW APPLICATION ENTERED
11/25/2024
Continuous trademark protection
Get notified about every new filing that threatens MISSION: GENOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.